Concord Drugs Ltd Screener
Small Cap
With a marketcap of ₹ 37.53 Cr Stock is ranked 3822
Concord Drugs Investment Return
Short Term
-1.24 %
2.63 %
-0.79 %
5.84 %
Long Term
9.64 %
26.79 %
108.50 %
87.74 %
Concord Drugs Return Calculator
₹
Concord Drugs Revenue and Profit and Growth
- No Strength found.
- No Weakness found.